Every material Form 8-K Renatus Tactical Acquisition Corp I has filed with the SEC since June 09, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Devin G. Nunes notified the board of Renatus Tactical Acquisition Corp I on October 31, 2026, that he is resigning as a director and as Chairman, effective the same day. The company said the resignation was not due to any dispute or disagreement over its operations, policies or practices. The board now has three independent directors, one non-independent director and one vacant seat, and the company is searching for an independent director to fill it.
Devin G. Nunes resigned as director and Chairman of the Board, effective October 31, 2026
The company states the resignation was not due to any dispute or disagreement with the company or board
Board now has three independent directors, one non-independent director and one vacant seat
The company is currently searching for an independent director to join the board
Renatus Tactical Acquisition Corp I, a special purpose acquisition company, appointed Lauren Selig as a director effective July 21, 2026, and added her to the Audit, Compensation, and Nominating and Corporate Governance committees. The sponsor will transfer 50,000 Class B ordinary shares to her as compensation for her board service, which is a routine governance change with limited direct effect on shareholders.
Board appointed Lauren Selig as a director on July 21, 2026, effective immediately
Selig joins the Audit, Compensation, and Nominating and Corporate Governance committees
Sponsor International SPAC Management Group I LLC will transfer 50,000 Class B ordinary shares to Selig for her director services
Selig signed an indemnity agreement and a letter agreement on the same terms as existing directors and officers, including a commitment to vote in favor of the initial business combination
Matan Fattal resigned as a director and from the Audit, Compensation, and Nominating and Corporate Governance committees, effective June 5, 2026, and the filing says the resignation was not due to any disagreement with the company or its board. Following his departure, the company notified Nasdaq that it no longer meets audit committee and board independence requirements, and it intends to rely on cure periods while it searches for an independent director.
Matan Fattal resigned as director and from three board committees, effective June 5, 2026.
On June 8, 2026, the company notified Nasdaq that its audit committee no longer meets the three-member, independent-director requirement under Rule 5605(c)(2)(A).
The board now has two independent directors, two non-independent directors, and one vacant seat, so it no longer has an independent majority, a temporary noncompliance under Rule 5605(b).
The company intends to use Nasdaq cure periods and is searching for an independent director to join the board and audit committee.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Renatus Tactical Acquisition Corp I filing is on SEC EDGAR ↗. 8-K briefs of other companies →